Distinct gene expression profiles in gastric epithelial cells induced by different clinical isolates of Helicobacter pylori - Implication of bacteria and host interaction in gastric carcinogenesis

Hepato-Gastroenterology

Volumn 53, Issue 70, 2006, Pages 484-490

  Chang, Yu Ting ^a   Wu, Ming Shiang ^a   Chang, Ya Jen ^a   Chen, Ching Chow ^a   Lin, Yi Shing ^b   Hsieh, Tracy ^b   Yang, Pan Chyr ^a   Lin, Jaw Town ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Section 2   (Taiwan)

Author keywords

C EBP ; Gastric cancer; Helicobacter pylori (H. pylori); Microarray

Indexed keywords

COMPLEMENTARY DNA; ENDOPEPTIDASE LA; VASCULOTROPIN;

ARTICLE; BACTERIUM ISOLATE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA MICROARRAY; DUODENUM ULCER; EPITHELIUM CELL; GENE EXPRESSION; GENETIC ANALYSIS; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; MOLECULAR CLONING; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; RNA EXTRACTION; STOMACH CANCER; STOMACH EPITHELIUM;

CELL LINE, TUMOR; DUODENAL ULCER; EPITHELIAL CELLS; GASTRIC MUCOSA; GENE EXPRESSION; GENE EXPRESSION PROFILING; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; STOMACH NEOPLASMS;

EID: 33748652682     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-789.
2. Miwa H, Go MF, Sato N: H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol 2002; 97:1106-1112.
3. Peek RM Jr., Blaser M J: Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2:28-37.
4. Go MF, Kapur V, Graham DY, Musser JM: Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol 1996; 178:3934-3938.
5. Blaser MJ, Berg DE: Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001; 107:767-773.
6. Moss SF, Calam J, Agarwal B, Wang S, Holt PR: Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38:498-501.
7. Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM: Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997; 151:1695-1703.
8. Kohda K, Tanaka K, Aiba Y, Yasuda M, Miwa T, Koga Y: Role of apoptosis induced by Helicobacter pylori infection in the development of duodenal ulcer. Gut 1999; 44:456-462.
9. Peek RM Jr., Moss SF, Tham KT, et al: Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 1997; 89:863-868.
10. Rokkas T, Ladas S, Liatsos C, et al: Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig Dis Sci 1999; 44:487-493.
11. Blaser M J, Perez-Perez G I, Kleanthous H, Cover T L, Peek R M, Chyou P H, Stemmermann G N, Nomura A: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-2115.
12. Censini S, Lange C, Xiang Z, Crabtree J E, Ghiara P, Borodovsky M, Rappuoli R, Covacci A: cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93:14648-14653.
13. Ito Y, Azuma T, Ito S, Suto H, Miyaji H, Yamazaki Y, Kato T, Kohli Y, Keida Y, Kuriyama M: Sequence analysis and clinical significance of the iceA gene from Helicobacter pylori strains in Japan. J Clin Microbiol 2000; 38:483-488.
14. Maeda S, Kanai F, Ogura K, Yoshida H, Ikenoue T, Takahashi M, Kawabe T, Shiratori Y, Omata M: High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan. Dig Dis Sci 1997; 42:1841-1847.
15. Yang JC, Kuo CH, Wang HJ, Wang TC, Chang CS, Wang WC: Vacuolating toxin gene polymorphism among Helicobacter pylori clinical isolates and its association with m1, m2, or chimeric vacA middle types. Scand J Gastroenterol 1998; 33:1152-1157.
16. Wang HJ, Kuo CH, Yeh AA, Chang PC, Wang WC: Vacuolating toxin production in clinical isolates of Helicobacter pylori with different vacA genotypes. J Infect Dis 1998; 178:207-212.
17. Sepulveda AR, Tao H, Carloni E, Sepulveda J, Graham DY, Peterson LE: Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis. Aliment Pharmacol Ther 2002; 16(Suppl 2):145-157.
18. Chiou CC, Chan CC, Sheu DL, Chen KT, Li YS, Chan EC: Helicobacter pylori infection induced alteration of gene expression in human gastric cells. Gut 2001; 48:598-604.
19. Maeda S, Otsuka M, Hirata Y, Mitsuno Y, Yoshida H, Shiratori Y, Masuho Y, Muramatsu M, Seki N, Omata M: cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells. Biochem Biophys Res Commun 2001; 284:443-449.
20. Israel DA, Salama N, Arnold CN, Moss SF, Ando T, Wirth HP, Tham KT, Camorlinga M, Blaser MJ, Falkow S, Peek RM Jr: Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest 2001; 107:611-620.
21. Hsu PI, Hwang IR, Cittelly D, Lai KH, El-Zimaity HM, Gutierrez O, Kim JG, Osato MS, Graham DY, Yamaoka Y: Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol 2002; 97:2231-2238.
22. Nilsson C, Sillen A, Eriksson L, Strand ML, Enroth H, Normark S, Falk P, Engstrand L: Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal disease. Infect Immun 2003; 71:6573-6581.
23. Poli V: The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 1998; 273:29279-29282.
24. Greenbaum LE, Cressman DE, Haber BA, Taub R: Coexistence of C/EBP alpha, beta, growth-induced proteins and DNA synthesis in hepatocytes during liver regeneration. Implications for maintenance of the differentiated state during liver growth. J Clin Invest 1995; 96:1351-1365.
25. Caivano M, Gorgoni B, Cohen P, Poli V: The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta) and C/EBP delta transcription factors. J Biol Chem 2001; 276:48693-48701.
26. Oya M, Horiguchi A, Mizuno R, Marumo K, Murai M: Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma. Clin Cancer Res 2003; 9:1021-1027.
27. Zhu S, Yoon K, Sterneck E, Johnson PF, Smart RC: CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc Natl Acad Sci USA 2002; 99:207-212.